Jersey City, NJ, United States of America

Gayle E Taylor


 

Average Co-Inventor Count = 6.3

ph-index = 4

Forward Citations = 79(Granted Patents)


Location History:

  • Red Bank, NJ (US) (2012)
  • Jersey City, NJ (US) (2010 - 2014)

Company Filing History:


Years Active: 2010-2014

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Innovator Profile: Gayle E. Taylor from Jersey City, NJ

Introduction

Gayle E. Taylor is a distinguished inventor based in Jersey City, NJ, who has made significant contributions to the field of pharmaceutical sciences. With a portfolio of eight patents, her work focuses on developing innovative compounds that address crucial health issues, particularly in the realm of cardiovascular diseases.

Latest Patents

Among her latest patents are the Cholesteryl Ester Transfer Protein (CETP) inhibitors, described as compounds of Formula (I). These compounds, including their pharmaceutically acceptable salts, have shown promise in raising HDL-cholesterol, reducing LDL-cholesterol, and in the treatment or prevention of atherosclerosis. The compounds feature a cyclic group represented as A, and another cyclic group denoted as B, which is directly attached to the heterocyclic ring or connected through a methylene group. This innovative approach to CETP inhibition highlights her commitment to advancing therapeutic options for cardiovascular health.

Career Highlights

Throughout her career, Gayle has collaborated with leading pharmaceutical companies, including Merck Sharp & Dohme Corporation and Merck & Company, Inc. Her expertise and dedication have positioned her as a notable figure in the industry, fostering advancements that can improve patient outcomes.

Collaborations

In her journey as an inventor, Gayle has worked alongside accomplished colleagues, including Amjad Ali and Peter J. Sinclair. These collaborations have enriched her contributions and further propagated her innovative insights within her research and development endeavors.

Conclusion

Gayle E. Taylor exemplifies the spirit of innovation through her commitment to addressing significant health challenges with her inventions. Her work not only enhances our understanding of cholesterol management but also paves the way for future developments in the treatment of atherosclerosis. As she continues to push the boundaries of pharmaceutical innovation, her influence will undoubtedly inspire many aspiring inventors in the years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…